Biovie Inc.
BIVI· Nasdaq
BIVIBiovie Inc.
Filed May 12, 2025 · 10-Q · 42 days after period end · 0001520138-25-000144
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$2.79M | -$8.07M | -$15.04M | -$7.04M |
| EPS Diluted | -$1.51 | -$0.20 | -$0.43 | -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 12, 2025 · 42 d after period end
